Stocks and Investing Stocks and Investing
Fri, May 8, 2020

Swayampakula Ramakanth Reiterated (XFOR) at Buy with Decreased Target to $21 on, May 8th, 2020


Published on 2024-10-27 05:55:08 - WOPRAI, Swayampakula Ramakanth
  Print publication without navigation


Swayampakula Ramakanth of HC Wainwright & Co., Reiterated "X4 Pharmaceuticals, Inc." (XFOR) at Buy with Decreased Target from $22 to $21 on, May 8th, 2020.

Swayampakula has made no other calls on XFOR in the last 4 months.



There is 1 other peer that has a rating on XFOR. Out of the 1 peers that are also analyzing XFOR, 0 agree with Swayampakula's Rating of Hold.



This is the rating of the analyst that currently disagrees with Swayampakula


  • Joel Beatty of "Citigroup" Maintained at Strong Buy with Decreased Target to $15 on, Thursday, March 26th, 2020
Contributing Sources